|
1 Indications And Usage Trisenox Is An Arsenical Indicated: In Combination With Tretinoin For Treatment Of Adults With Newly-Diagnosed Low-Risk Acute Promyelocytic Leukemia (Apl) Whose Apl Is Characterized By The Presence Of The T(15;17) Translocation Or Pml/rar-Alpha Gene Expression. ( 1.1 ) For Induction Of Remission And Consolidation In Patients With Apl Who Are Refractory To, Or Have Relapsed From, Retinoid And Anthracycline Chemotherapy, And Whose Apl Is Characterized By The Presence Of The T(15;17) Translocation Or Pml/rar-Alpha Gene Expression. ( 1.2 ) 1.1 Newly-Diagnosed Low-Risk Apl Trisenox Is Indicated In Combination With Tretinoin For Treatment Of Adults With Newly-Diagnosed Low-Risk Acute Promyelocytic Leukemia (Apl) Whose Apl Is Characterized By The Presence Of The T(15;17) Translocation Or Pml/rar-Alpha Gene Expression. 1.2 Relapsed Or Refractory Apl Trisenox Is Indicated For Induction Of Remission And Consolidation In Patients With Apl Who Are Refractory To, Or Have Relapsed From, Retinoid And Anthracycline Chemotherapy, And Whose Apl Is Characterized By The Presence Of The T(15;17) Translocation Or Pml/rar-Alpha Gene Expression.
|